These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Thalidomide therapy for aggressive histiocytic lesions in the pediatric population.
    Author: Bailey KM, Castle VP, Hummel JM, Piert M, Moyer J, McAllister-Lucas LM.
    Journal: J Pediatr Hematol Oncol; 2012 Aug; 34(6):480-3. PubMed ID: 22810753.
    Abstract:
    Aggressive histiocytic lesions are uncommon in the pediatric population. These neoplasms occur in isolation or after therapy for other types of hematopoietic malignancy such as T-cell acute lymphoblastic leukemia. The etiology of these lesions is poorly understood, and no definitive standard of care has been established for patients with these diagnoses. Here, we report the success of thalidomide treatment for 2 subtypes of histiocytic proliferation--metastatic histiocytic sarcoma and extracutaneous juvenile xanthogranuloma--in pediatric patients. Our findings highlight the importance of considering thalidomide therapy in this unique and difficult to treat patient population.
    [Abstract] [Full Text] [Related] [New Search]